Cargando…
The incidence and clinical features of PEGylated filgrastim-induced acute aortitis in patients with breast cancer
Although PEGylated filgrastim-induced aortitis is very rare and unknown clinically, some cases were reported and increasing, especially in breast cancer patients. The present study investigated the prevalence, clinical features and treatment of aortitis induced by PEGylated filgrastim in patients wi...
Autores principales: | Lee, Sang Yoon, Kim, Eun Kyoung, Kim, Ji-Yeon, Park, Taek-kyu, Choi, Seung-Hyuk, Im, Young-Hyuck, Kim, Min Yeong, Park, Yeon Hee, Kim, Duk-Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596224/ https://www.ncbi.nlm.nih.gov/pubmed/33122662 http://dx.doi.org/10.1038/s41598-020-75620-6 |
Ejemplares similares
-
Immunoglobulin G4-Related Aortitis of the Abdominal Aorta
por: Choi, Jae Won, et al.
Publicado: (2019) -
Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar
por: Schwartzberg, Lee S, et al.
Publicado: (2018) -
Lymphocyte-activating gene 3 expression in tumor cells predicts immune checkpoint inhibitor response in triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023) -
Does anticoagulation needed for distally located incidental pulmonary thromboembolism in patients with active cancer?
por: Chang, Haseong, et al.
Publicado: (2019) -
Differential clinical manifestations and clinical outcome of cancer-related pulmonary embolism
por: Kim, Min Sun, et al.
Publicado: (2020)